{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:06:02Z","timestamp":1790791562651,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tmreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.tmrv.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T21:59:36Z","timestamp":1464386376000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations"],"prefix":"10.1016","volume":"30","author":[{"given":"Jeanne E.","family":"Hendrickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2016.05.008_bb0005","series-title":"The blood group antigen facts book","author":"Reid","year":"2004"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0010","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21307\/immunohematology-2019-379","article-title":"Update on HDFN: new information on long-standing controversies","volume":"22","author":"Eder","year":"2006","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-2115(00)00428-0","article-title":"Non\u2013anti-D antibodies in red-cell alloimmunization","volume":"92","author":"Moise","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-0528.1998.tb10059.x","article-title":"The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn","volume":"105","author":"Hadley","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcp\/92.1.89","article-title":"Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn","volume":"92","author":"Nance","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0050","series-title":"Blood ASH annual meeting supplement","article-title":"IgG alloantibodies agianst RBC induced by pregnancy or transfusion have unique glycosylation patterns which correlate with clinical outcomes of hemolytic disease of the fetus or newborn","author":"Sonneveld","year":"2015"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1056\/NEJM199803193381204","article-title":"Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia","volume":"338","author":"Vaughan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1537-2995.2003.00327.x","article-title":"Causes of fetal anemia in hemolytic disease due to anti-K","volume":"43","author":"Daniels","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0065","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V95.12.3662","article-title":"RHD gene deletion occurred in the rhesus box","volume":"95","author":"Wagner","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0070","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1537-2995.2002.00165.x","article-title":"Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service","volume":"42","author":"Finning","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0080","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1537-2995.2000.40101239.x","article-title":"Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA","volume":"40","author":"Ahaded","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0085","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1046\/j.1537-2995.2002.00239.x","article-title":"IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease","volume":"42","author":"Lambin","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1067\/mob.2001.112970","article-title":"Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization","volume":"184","author":"Oepkes","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0110","first-page":"457","article-title":"75: management of alloimmunization during pregnancy","volume":"108","author":"practice bulletin no","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2011.09.024","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study","volume":"206","author":"Lindenburg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.earlhumdev.2011.07.010","article-title":"Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization","volume":"87","author":"Rath","year":"2011","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000343261","article-title":"Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease","volume":"103","author":"Smits-Wintjens","year":"2013","journal-title":"Neonatology"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0145","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3109\/14767058.2012.718387","article-title":"Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease","volume":"25","author":"Corvaglia","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00431-010-1310-8","article-title":"Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn\u2014a prospective randomized controlled trial","volume":"170","author":"Elalfy","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2014-12-614446","article-title":"Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers","volume":"126","author":"Hauschner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12387","article-title":"Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model","author":"Santhanakrishnan","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0165","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/S0264-410X(03)00336-0","article-title":"Transfer of antibody via mother's milk","volume":"21","author":"Van de Perre","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0170","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1365-2222.2012.04043.x","article-title":"FcRn-mediated intestinal absorption of IgG anti-IgE\/IgE immune complexes in mice","volume":"42","author":"Paveglio","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0175","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/trf.12802","article-title":"The AABB recommendations for the choosing wisely campaign of the American Board of Internal Medicine","volume":"54","author":"Callum","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/tmrv.2003.50001","article-title":"Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed","volume":"17","author":"van der Schoot","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9378(85)90288-1","article-title":"Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?","volume":"151","author":"Bowman","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It's time to phase in RHD genotyping for patients with a serologic weak D phenotype","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.tmrv.2016.05.008_bb0195","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/trf.13074","article-title":"Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype","volume":"55","author":"Kacker","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<245::AID-AJH16>3.0.CO;2-4","article-title":"Successful prevention of post-transfusion Rh alloimmunization by intravenous rho (D) immune globulin (WinRho SD)","volume":"60","author":"Anderson","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1423-0410.2005.00637.x","article-title":"Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin","volume":"89","author":"Laspina","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0210","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.0041-1132.2004.04161.x","article-title":"Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin","volume":"44","author":"Nester","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajog.2006.10.895","article-title":"High additional maternal red cell alloimmunization after rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus","volume":"196","author":"Schonewille","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0220","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/trf.13231","article-title":"Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation","volume":"55","author":"Schonewille","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn","author":"Brinc","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-2478(02)00020-2","article-title":"On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis)","volume":"82","author":"Kumpel","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/trf.12880","article-title":"Prophylactic anti-D preparations display variable decreases in fc-fucosylation of anti-D","volume":"55","author":"Kapur","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0240","doi-asserted-by":"crossref","first-page":"e80460","DOI":"10.1371\/journal.pone.0080460","article-title":"Mice expressing RHAG and RHD human blood group genes","volume":"8","author":"Goossens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0245","doi-asserted-by":"crossref","first-page":"470242","DOI":"10.1155\/2014\/470242","article-title":"RhD specific antibodies are not detectable in HLA-DRB1(*)1501 mice challenged with human RhD positive erythrocytes","volume":"2014","author":"Bernardo","year":"2014","journal-title":"Adv Hematol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0250","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/bmj.1.5238.1486","article-title":"Experimental studies on the prevention of Rh haemolytic disease","volume":"1","author":"Finn","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.2007.00945.x","article-title":"Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers","volume":"93","author":"Kumpel","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0260","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1537-2995.2009.02481.x","article-title":"Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen","volume":"50","author":"Hendrickson","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0265","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1537-2995.2011.03162.x","article-title":"Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity","volume":"51","author":"Hendrickson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0270","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0275","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-387664-5.00003-0","article-title":"The control of adaptive immune responses by the innate immune system","volume":"109","author":"Schenten","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0285","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","article-title":"Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model","volume":"100","author":"Stowell","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2007.06764.x","article-title":"IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?","volume":"139","author":"Brinc","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2567.2008.02807.x","volume":"124","author":"Brinc","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0300","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.4049\/jimmunol.1500790","article-title":"IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcgamma receptors in a full mouse model","volume":"195","author":"Bernardo","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0305","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","article-title":"Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation","volume":"191","author":"Stowell","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tmrv.2009.03.002","article-title":"Antigen loss from antibody-coated red blood cells","volume":"23","author":"Zimring","year":"2009","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0315","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood-2014-10-569244","article-title":"Fcgamma-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments","volume":"125","author":"Taylor","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0320","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood.V126.23.3570.3570","article-title":"Anti-RhD mediates loss of RhD antigen following anti-RhD infusion","volume":"126","author":"Sullivan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.05.008_bb0325","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","article-title":"A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation","volume":"122","author":"Girard-Pierce","year":"2013","journal-title":"Blood"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796316300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T19:57:45Z","timestamp":1656619065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796316300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0887796316300116"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.05.008","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}